Annovis Bio, Inc. (ANVS)

Last Closing Price: 0.84 (2026-11-18)

EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Annovis Bio, Inc. (ANVS) had EBITDA of $-16.97M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-9.46M
--
--
$16.97M
$-16.97M
$7.51M
$-9.46M
$-9.46M
$-9.46M
$-9.46M
$-9.46M
$-9.46M
$-16.97M
EBITDA
$-16.97M
42.63M
42.63M
$-0.22
$-0.22
Balance Sheet Financials
$5.50M
--
--
$5.50M
$6.26M
--
$12.47M
$18.74M
$-13.23M
$-13.23M
$-13.23M
42.69M
Cash Flow Statement Financials
$-46.96M
--
$30.25M
$19.53M
$2.82M
$-16.71M
$2.15M
--
--
Fundamental Metrics & Ratios
0.88
--
--
--
--
--
--
--
--
--
--
$-46.96M
--
--
--
--
--
--
--
71.50%
71.50%
-171.92%
71.50%
$-0.31
$-1.10
$-1.10